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Introduction
On initial whole-body cold exposure there is an immediate decrease in skin temperature (T sk ) that elicits local and centrally induced constriction of the cutaneous circulation, which serves as a defence mechanism, preventing heat loss from the body in an attempt to delay the onset of hypothermia (Spealman, 1945; Granberg, 1991; Kenney & Armstrong, 1996) . In exchange for the protection of deep body temperature, an individual is at risk of other cold injuries, such as non-freezing cold injury (NFCI), with the feet more susceptible than the hands (Ungley & Blackwood, 1942) . Symptoms of this injury often include pain, whilst mild cooling of the affected extremity is associated with an exaggerated vasoconstrictor response and slow rewarming that may leave an individual prone to further cold injuries. These symptoms may last for the remaining lifetime of an individual (Ungley et al. 1945) .
In the military, particularly during conflict, cold injuries have resulted in hundreds of thousands of casualties (Paton, 2001; Golden et al. 2013) . In the UK Armed Forces, between 2006 and 2016, there were 1235 successful personnel compensation claims for NFCI, with the most recent year (March 2015 (March -2016 costing the Ministry of Defence £1,486,200. However, NFCI is not solely a military problem, as cases have been reported in civilians (Ramstead et al. 1980; Wrenn, 1991) and in those who expose themselves to cold during leisure activities, such as mountaineering or cold expeditions (O'Brien & Frykman, 2003) . Recently, 'Sport England' (Anonymous, 2016) reported that nearly 1.5 million individuals participate each month in sports that may involve cold exposure, such as angling, water sports, mountaineering and snow sports; therefore, the risk of NFCI is ever-present.
A major predisposing risk factor on the incidence of NFCI is ethnicity. Individuals of African descent (AFD) are more susceptible to cold injuries compared with Caucasian individuals (CAU) in the same environmental conditions (DeGroot et al. 2003; Burgess & Macfarlane, 2009) . Within the US Armed Forces between 2009 and 2014 there were 3008 individuals who suffered a cold injury, with AFD injured at twice the rate of CAU (Connor, 2014) . Despite increased awareness and education, NFCI and other cold injuries remain a current issue.
The mechanism(s) for the increased incidence of NFCI in AFD is not clear at present. During local hand cooling (8°C for 30 min) and spontaneous rewarming, we have previously observed that AFD experience greater vasoconstriction and also rewarm later and more slowly than CAU (Maley et al. 2014) . The comparatively lower skin blood flow and lower T sk in AFD may explain the increased susceptibility to NFCI. In addition, we have shown that AFD appear to have a reduced endothelial function, showing a smaller vasodilatory response to ACh compared with CAU (Maley et al. 2015 (Maley et al. , 2017 ; however, the reason for the differences in response to local cooling remains unclear.
During local cooling, the decrease in skin blood flow is a result of sympathetic adrenergic activation releasing noradrenaline that acts on postsynaptic adrenergic receptors (Pergola et al. 1993; Johnson et al. 2005) , as well as an inhibition of nitric oxide production and contributions from non-adrenergic pathways (Hodges et al. 2006; Thompson-Torgerson et al. 2007; Johnson et al. 2014) . Furthermore, cooling increases reactive oxygen species (Bailey et al. 2005) which, along with reducing the bioavailability of nitric oxide, lead to translocation of α 2C -receptors to the cell surface, capable of exaggerating the response to local cooling (Chotani et al. 2000 (Chotani et al. , 2004 . Compared with CAU, in vivo and in vitro data demonstrate that AFD experience heightened oxidative stress and reduced bioavailability of nitric oxide (Kalinowski et al. 2004; Feairheller et al. 2011) . This oxidative stress may be produced from various sources, such as nicotinamide adenine dinucleotide phosphate (NADPH) oxidase and cyclooxygenase (COX; Kukreja et al. 1986; Griendling & FitzGerald, 2003; Vanhoutte, 2011) . Along with other prostanoids, COX produces thromboxane A 2 , a vasoconstrictor that plays a role in the cold-induced vasoconstriction in response to hand cooling in those with Raynaud's phenomenon (Tindall et al. 1985) , demonstrating that thromboxane A 2 may play a role in those with altered vascular function. Coupled with the information that AFD experience greater levels of oxidative stress, perhaps produced through COX, and that COX increases reactive oxygen species and produces thromboxane A 2 , it is possible that this enzyme might contribute to the accentuated vasoconstrictor response in AFD during local cooling.
The aim of the present study, therefore, was to determine whether the accentuated vasoconstrictor response during local cooling and the delayed release during rewarming in AFD involves the COX pathway. It was hypothesized that COX inhibition would attenuate the local cooling-induced vasoconstriction and result in AFD experiencing local vascular responses similar to CAU.
Methods
This study was given a favourable ethical opinion from the University of Portsmouth Science Faculty Ethics Committee (approval no. SFEC 2014 -050) and complied with standards set in the Declaration of Helsinki (October 2013). The participants were made aware of the purpose, procedures and risks of the study before giving their informed written consent. Twelve CAU and 12 AFD male volunteers participated in the study; their physical characteristics are presented in Table 1 . All CAU were born in the UK. Eight AFD were born in the UK, whereas four were born in Africa (Zimbabwe, Ghana, Kenya and Uganda) and had resided in the UK for an average of 11 years, with a minimum of 7 years. All participants were non-smokers and were free from asthma and any vascular or blood disorders including hypertension, diabetes and Raynaud's phenomenon, with no history of either freezing or non-freezing cold injuries. Participants' history of cold exposure was ascertained by questionnaire, with each ethnic group reporting similar exposure to cold. Ethnicity was determined by self-classification. To minimize heterogeneity, participants were recruited only if both parents and all four grandparents were known to originate from the same ethnic group. Before testing, participants were asked to refrain from consumption of alcohol for 24 h and from participation in exercise or consumption of caffeine for 12 h.
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Experimental procedures and measurements
In a balanced, cross-over, placebo-controlled design, participants were required to attend the laboratory on two separate occasions at the same time of day. Both visits included immersion of the foot and hand, separately, into cold water. Given that we had previously observed no ethnic differences in T sk and skin blood flow between ethnic groups in response to foot immersion in 15°C water for 2 min (Maley et al. 2014) , we decided to use a cold-induced vasodilatation (CIVD) protocol, as used previously (Maley et al. 2014) , consisting of immersion in water at 8°C for 30 min for both the foot and hand cooling. Previous research has demonstrated greater reactivity and comfort in response to 8°C water compared with colder water (Mekjavic et al. 2013; Tyler et al. 2015) . For every participant, foot cooling was performed first, followed by hand cooling.
Immediately before entering the climate-controlled chamber, participants were asked to consume 150 ml of diluted orange squash with or without soluble aspirin (acetylsalicylic acid; 600 mg; Boots Inc., Portsmouth, UK), blinded to the participant. Aspirin irreversibly inhibits COX by acetylation of the active site of COX (Vane, 1971) , with this dose of aspirin shown to inhibit 86% of bradykinin-induced production of prostacyclin and 99% inhibition of thromboxane A 2 production by platelets at 30 min (Heavey et al. 1985) .
Participants entered the climate-controlled chamber [mean (SD) dry bulb temperature, 30.3 (0.9)°C, wet bulb temperature, 22.9 (0.9)°C and wet bulb globe temperature, 25.1 (0.9)°C], removed their socks and shoes and rested in a semi-recumbent position for 25 min whilst being instrumented. A laser Doppler probe (VP1T / 7; Moor Instruments, UK) was applied to the great toe of the right foot using double-sided adhesive rings to measure skin blood flow using a laser Doppler flowmetry monitor (moorVMS-LDF; Moor Instruments, Axminster, UK). Laser Doppler data were recorded using a data acquisition system and software (Powerlab and LabChart 7; AD Instruments, Dunedin, New Zealand). A thermistor (Type EUS-U; Grant Instruments, Cambridge, UK) was applied to the medial aspect of the great toe pad of the right foot using a single piece of adhesive tape. The skin temperature (T sk ) was measured using a squirrel 1200 series data logger (Grant Instruments) and recorded every 5 s.
After the 25 min rest period, participants placed their right foot into a plastic bag and immersed it up to the point of the mid-malleoli in a stirred water-bath (Grant Instruments) maintained at 35.0 (0.3)°C for 5 min. Next, participants removed their foot, still within the plastic bag, from the water-bath and immediately placed it into a stirred water-bath maintained at 8.2 (0.1)°C for a further 30 min. After foot cooling, participants removed their foot from the water-bath and plastic bag to allow spontaneous rewarming of the foot for 15 min. After this, participants were given 150 ml of diluted orange squash with or without soluble aspirin (300 mg). The reason for adding an extra dose of aspirin is because of the return of endothelial COX function within 90 min and to ensure that COX function was inhibited as much as possible (Heavey et al. 1985) . If a participant received aspirin at the beginning of the protocol, they also received aspirin in their second drink; if the participant was not given aspirin in their first drink, then they were not given aspirin in their second drink (Fig. 1) .
Within the next 25 min, participants were instrumented for their hand immersion protocol. A laser Doppler probe and skin thermistor were placed onto the participant's middle and second finger, respectively, of the right hand. Participants then placed their hand into a plastic bag and immersed it to the styloid process in a water-bath maintained at 35.0 (0.2)°C for 5 min. The protocol for the hand was the same as for the foot, in that cooling [8.1 (0.1)°C] and spontaneous rewarming followed. Blood pressure was measured from the left arm, using an automated monitor (Minimon 7137 Plus; Kontron Instruments, Watford, UK), for both the foot and hand cooling protocols, and recorded 2 min before cooling, and at 30 s, 5 and 15 min into cooling, followed by 30 s and 5 min into rewarming.
Participants' height and mass were measured using a stadiometer (Bodycare, Leicester, UK) and digital weighing scales (Ohaus I-10; Ohaus Corporation, Parsippany, NJ, USA), respectively. The length of the participant's hand and foot was measured using a segmometer (Segmometer 4; Rosscraft, Surrey, Canada). Hand and foot volume was calculated using a water displacement method.
Data analyses
As mean arterial pressure {MAP = [(2 × diastolic) + systolic]/3} differed over time (see Results), skin blood flow was calculated as cutaneous vascular conductance [CVC; laser Doppler units/MAP = CVC (expressed as flux per millimetre of mercury)]. Skin temperature was plotted every 5 min and, from the sampled data that were recorded every 5 s, the CIVD variables were determined, which included the following: average T sk ; minimum T sk ; number of CIVD waves; onset time of first CIVD wave; T sk before onset of first CIVD wave; maximum T sk during the first CIVD wave; and amplitude of CIVD wave (Fig. 2) . For the skin blood flow assessment during local cooling and rewarming, the average, minimum and area under the curve (AUC, calculated using GraphPad, Version 5; GraphPad Software Inc., La Jolla, CA, USA) were calculated. Statistical analyses were conducted using IBM SPSS for Windows version 20 (IBM SPSS Statistics, Armonk, NY, USA). Data were assessed for normality with a Shapiro-Wilk test. An α of 0.05 was used to determine statistical significance. Participant characteristics were analysed using Student's unpaired t test. The MAP throughout immersion was analysed between and within groups with a repeated-measures ANOVA to identify any differences in blood pressure between ethnicities and between COX inhibition and placebo. Where a significant main effect was observed (see Results), pairwise comparisons were carried out and adjusted for multiple comparisons using the Holm-Bonferroni procedure.
Baseline CVC (i.e. final minute of warm water immersion) between and within groups was analysed using Student's unpaired and paired t test, respectively. Baseline T sk (i.e. final 5 s of warm water immersion) between and within groups was analysed using a Mann-Whitney U test and a Wilcoxon signed rank test, respectively. Cold-induced vasodilatation variables, CVC average, minimum and AUC during cooling and rewarming between groups were analysed using either Student's unpaired t test or a Mann-Whitney U test. The same variables within groups were analysed using Student's paired t test or a Wilcoxon signed rank test. Between-and within-groups CVC and T sk throughout immersion were analysed using a Mann-Whitney U test and Wilcoxon signed rank test, respectively, and adjusted for multiple comparisons using the Holm-Bonferroni procedure.
Parametric data in text are presented as the mean (SD), whereas non-parametric data are presented as the median and interquartile range (IQR). Figures shown are presented as the mean (SD). Effect sizes, where appropriate, were calculated and are denoted by d for parametric data and r for non-parametric data.
Results
Participants
All participant characteristics were similar (P > 0.05), except that AFD had a longer hand length (P = 0.018, d = 1.04) and a greater hand volume (P = 0.043, d = 0.87) than CAU.
Mean arterial pressure
There was no main effect for ethnicity or condition (i.e. placebo versus COX inhibition) for both foot and hand immersion protocols [mean (SD): baseline placebo, foot, CAU, 83 (5) mmHg and AFD, 83 (7) mmHg; hand, CAU, 82 (7) mmHg and AFD, 81 (8) mmHg, P > 0.05]. However, there was a main effect for time for both the foot (P < 0.001) and hand (P = 0.022) protocols, with pairwise comparisons showing MAP elevated for the first 5 min of immersion in the foot protocol only (Table 2) . There was no statistical interaction between condition, time and ethnicity for both immersion protocols (P > 0.05).
Baseline skin blood flow and skin temperature
After COX inhibition, CAU had lower baseline toe CVC (Table 3 ; P = 0.019, d = 1.03) and T sk (Table 3 ; P = 0.045, r = 0.41) than AFD. Otherwise, baseline values were similar (Table 3) .
Foot responses to cooling and subsequent rewarming
Skin blood flow. Toe skin blood flow during foot cooling and rewarming was similar between and within groups Extremity cooling and cyclooxygenase inhibition after placebo and COX inhibition (Table 4 and Fig. 3A ; P > 0.05).
Skin temperature. There was a tendency for CAU to have a lower average T sk compared with AFD after COX inhibition (Table 5 ; P = 0.052, d = 0.84). After placebo, only two CAU and four AFD experienced CIVD. After COX inhibition, only two CAU and seven AFD experienced CIVD. Therefore, analyses on these variables could not be conducted. Toe T sk during foot cooling and rewarming was similar between and within groups after placebo and COX inhibition ( Fig. 3B ; P > 0.05).
Finger responses to cooling and subsequent rewarming
Skin blood flow. During cooling, COX inhibition resulted in a higher minimum CVC in AFD compared with placebo (Table 6 ; P = 0.039, d = 0.78). During cooling, after placebo, the minimum CVC was lower in AFD compared with CAU (P < 0.001, d = 2.03), whilst there was a tendency for average CVC (P = 0.050, d = 0.84) and AUC (P = 0.053, d = 0.83) to be lower in AFD compared with CAU. During rewarming, AFD had lower average CVC (P = 0.009, d = 1.17) and AUC (P = 0.009, d = 1.18) compared with CAU.
During cooling, after COX inhibition, there was a tendency for average CVC (P = 0.052, d = 0.85) and AUC (P = 0.055, d = 0.84) to be lower in AFD compared with CAU. During rewarming, AFD experienced a lower average CVC (P < 0.001, d = 1.69), minimum CVC (P = 0.017, d = 1.05) and AUC (P = 0.001, d = 1.63) compared with CAU.
During cooling and subsequent rewarming, finger skin blood flow was lower in AFD than CAU after both placebo and COX inhibition (Fig. 4A) .
Skin temperature. For CAU, COX inhibition resulted in a warmer average finger T sk (Table 7 ; P = 0.049, r = 0.28) and a faster onset time of CIVD (P = 0.035, r = 0.13) compared with placebo. Minimum finger T sk was lower in AFD compared with CAU after both placebo (P = 0.004, d = 1.30) and COX inhibition (P = 0.034, d = 0.92).
Finger T sk during cooling and rewarming was lower in AFD compared with CAU after both placebo and COX inhibition (Fig. 4B ).
Discussion
The primary findings of this study were as follows: (i) during foot cooling, toe skin blood flow (Fig. 3A) and T sk (Fig. 3B) did not differ between ethnic groups irrespective of COX inhibition; and (ii) during local hand cooling, AFD experienced significantly lower finger skin blood flow (Fig. 4A ) and T sk (Fig. 4B ) compared with CAU irrespective of COX inhibition. After placebo, the present study confirms previous findings between CAU and AFD in response to hand cooling (Iampietro et al. 1959; Newman, 1969; Jackson et al. 1989; Maley et al. 2014) , whereas the responses to foot cooling (8°C for 30 min) are the first to be reported here. Contrary to our hypothesis, these data suggest that in young AFD healthy males the COX pathway appears not to be the primary reason for the increased susceptibility to NFCI.
During foot cooling, AFD responded in a comparable manner to CAU. Given that NFCI is more prominent in the feet and AFD are more susceptible to NFCI, it was expected that CAU would respond to foot cooling with warmer T sk and greater skin blood flow responses compared with AFD. The authors are not sure why no ethnic differences were observed in the direction expected. Thickness of the skin might be a contributing factor, as the authors noted that the skin on the sole of the foot in participants of African descent felt 'thicker' . Although the thickness of the stratum corneum is similar between African and European individuals on skin sites such as the hip, arm and face (Thomson, 1955; Freeman et al. 1962; Richards et al. 2003) , the deeper dermis layer is thicker in AFD (Richards et al. 9.3 (4.1) 10.9 (7.8) 9.1 (2.4) 12.6 (6.6) Abbreviations: CIVD, cold-induced vasodilatation; and T sk , skin temperature. †Median (IQR). * P = 0.052. n = 12 for average and minimal T sk . Abbreviation: AUC, area under the curve. * Significant difference between CAU and AFD (P < 0.05). †Significant difference (P < 0.05) between placebo and COX inhibition. n = 12 for each group.
2003)
. If the skin (epidermis or dermis) is thicker on the sole of the foot in African individuals then this might have provided some protection (insulation) from the cold stimulus and hidden a dysfunctional microvascular response. Stratum corneum thickness has been discussed previously as a factor that may influence finger cooling rates (Jay & Havenith, 2004) . However, as previously observed (Maley et al. 2014) , it is possible that AFD do not experience a dysfunctional response to local foot cooling without centrally driven vasoconstriction. Interestingly, during foot cooling some participants experienced a very strong local vasoconstrictor response, whereas others exhibited only slight changes. The reason for the variability is not known. Individuals born in a tropical climate may experience exaggerated responses to local finger cooling (Lee et al. 2013) ; however, eight of the 12 participants in this study were born in the UK, with the four born outside the UK not primarily responsible for the variability. Although participants reported similar exposure to cold, other factors, such as differences in deep body temperature (Daanen et al. 1997 ) and physical fitness (Keramidas et al. 2010) , might have contributed to the variability in responses.
The present study does not lend support to a previous pilot study (Belvins et al. 2014) , where it was suggested that COX inhibition in CAU may facilitate local skin blood flow during foot cooling and spontaneous rewarming. The present study used a colder water temperature (8 versus 15°C) and one immersion of 30 min in comparison to three repeated immersions of 10 min in the pilot study. Different cooling rates and durations between the two studies may have contributed to the conflict in results; however, further elaboration of differences between studies is not possible at present given the little information available.
Using forearm and finger venous occlusion plethysmography, previous research has demonstrated that the reflex vascular responses to arm or foot cooling are not altered by COX inhibition (Cowley et al. 1983 (Cowley et al. , 1985 Gresele et al. 1985; Hechtman & Jageneau, 1985) , with one study demonstrating an increase in vascular resistance during foot cooling (Serneri et al. 1981) . As the and skin temperature (in degrees Celsius; B) during hand cooling and subsequent spontaneous rewarming after placebo and COX inhibition * Significant difference (P < 0.05) between CAU and AFD after placebo. † Significant difference (P < 0.05) between CAU and AFD after COX inhibition. Note that the SD is included for the CAU placebo protocol only for reader clarity. Extremity cooling and cyclooxygenase inhibition present study observed the local vascular response (using laser Doppler flowmetry) to local cooling, the results are difficult to compare with previous studies as reflex vasoconstriction is controlled in a different manner from local vasoconstriction (Johnson et al. 2014) . As hypothesized, during hand immersion, the fingers of AFD reached a lower temperature and rewarmed more slowly than those of CAU, confirming our previous findings (Maley et al. 2014) . We also hypothesized that COX inhibition in AFD would result in warmer finger T sk during hand cooling and spontaneous rewarming, making their response similar to CAU, although this did not occur. As alluded to within the Introduction, we hoped that COX inhibition would attenuate the production of reactive oxygen species and, in turn, reduce the vasoconstriction experienced by AFD during local hand cooling. However, the present study appears to provide evidence that COX is not the major cause for the greater vasoconstrictor response and cooler T sk in response to local hand cooling in AFD. The authors can only speculate that other sources of oxidative stress, such as NADPH oxidase (Griendling & FitzGerald, 2003) , are partly responsible for the exaggerated responses experienced by AFD. Antioxidants capable of scavenging oxygen-derived free radicals before cooling should be investigated in future studies.
Despite COX inhibition not providing any advantage to AFD during local hand cooling, it was noted that CAU experienced a warmer average finger T sk and earlier CIVD onset time (Table 7) after COX inhibition versus placebo. The difference in average finger T sk was 0.6°C, and only four participants were included in the analyses for the CIVD onset time; therefore, caution should be exercised when interpreting the present results. Additionally, it should be noted that use of COX inhibition (e.g. acetaminophen) before whole-body cooling may lead to a faster decline in deep body temperature (Foster et al. 2016) . Although COX inhibition may produce warmer finger T sk during local cooling, the authors do not recommend administration of aspirin, or any other COX inhibitor, to an individual susceptible to NFCI.
Factors other than local cutaneous vasculature control may play a role in the increased susceptibility to NFCI in AFD. Previous research has shown that AFD compared with CAU experience a lower deep body temperature, finger T sk and oxygen uptake during whole-body cooling (Rennie & Adams, 1957; Adams & Covino, 1958; Farnell et al. 2008) . Given that the CIVD responses are blunted with colder environments or lower deep body temperatures (Keatinge, 1957; Sawada et al. 2000; Dobnikar et al. 2009) , it is possible that factors such as thermogenesis and/or centrally driven vasoconstriction, in combination with a depressed CIVD reaction (at least in the hands) during whole-body cooling, may play a role in the increased susceptibility to NFCI in AFD. Further studies are being conducted to elucidate the extremity vascular responses to whole-body cooling between CAU and AFD.
It is concluded that young, healthy, male AFD and CAU show similar physiological responses to foot cooling. In contrast, compared with CAU, AFD experience lower finger skin blood flow and cooler finger T sk in response to hand cooling irrespective of COX inhibition. Therefore, it is unlikely that the COX pathway is responsible for the increased susceptibility to NFCI in AFD.
